Insulin Aspart (NovoRapid)

Fast-acting insulin analogue with aspartic acid substitution, rDNA origin, used for mealtime glycemic control. Classified in 2937.12.00.00 as insulin structural analogue per heading description for chain-modified polypeptides used as hormones.

Import Duty Rates by Country of Origin

Origin CountryMFN RateCh.99 SurchargesTotal Effective Rate
🇨🇳ChinaFreeFree
🇲🇽MexicoFreeFree
🇨🇦CanadaFreeFree
🇩🇪GermanyFreeFree
🇯🇵JapanFreeFree

Alternative Classifications

This product could be classified differently depending on its characteristics or intended use.

3004.39.00Same rate: Free

If formulated in final dosage presentation

Pharmaceutical preparations exclude pure hormones; Chapter 30 takes precedence.

2937.11.00Same rate: Free

If classified as other polypeptide hormones

Heading hierarchy places insulin specifically at 2937.12; others at 2937.11.

Not sure which classification is right?

Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.

Import Tips & Compliance

Include batch-specific certificates of analysis showing >97% purity and correct sequence

Refrigerated transport with validated packaging; temperature excursions void bioactivity

Distinguish bulk API from finished products to maintain Chapter 29 classification

Related Products under HTS 2937.12.00.00

Human Insulin (rDNA)

Recombinant human insulin produced via DNA technology, a polypeptide hormone used primarily for treating diabetes mellitus. Classified under HTS 2937.12.00.00 as a synthetic reproduction of insulin, the exact structural analogue of natural human insulin. Meets chapter 29 requirements for chemically defined organic compounds used as hormones.

Insulin Lispro (Humalog)

Rapid-acting insulin analogue created by recombinant DNA technology with amino acid modifications for faster absorption. Falls under HTS 2937.12.00.00 as a structural analogue of insulin used primarily as a hormone for glycemic control. Qualifies as a chain-modified polypeptide hormone per chapter notes.

Insulin Glargine (Lantus)

Long-acting basal insulin analogue produced by recombinant DNA, modified for prolonged release profile. HTS 2937.12.00.00 covers this as a derivative and structural analogue of insulin used primarily as a hormone. Chemically defined polypeptide meeting Chapter 29 hormone classification criteria.

Insulin Detemir (Levemir)

Soluble long-acting insulin analogue with fatty acid modification for albumin binding. HTS 2937.12.00.00 applies to this rDNA-produced derivative used primarily as a basal insulin hormone replacement.

Insulin Sodium Salt USP

Pharmaceutical grade sodium salt of bovine or porcine insulin meeting USP standards. Explicitly covered by HTS 2937.12.00.00 as 'insulin and its salts' for therapeutic hormone use.

Recombinant Insulin API Powder

Bulk active pharmaceutical ingredient powder of human insulin produced by recombinant E. coli or yeast. HTS 2937.12.00.00 for pure synthetic insulin substance before formulation into dosage forms.